Aival Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Aival General Information

Description

Developer of a healthcare platform for evaluating and monitoring healthcare products designed to facilitate the adoption of reliable and secure AI. The company's platform offers a scalable and independent assessment of artificial intelligence products, ensuring their performance, fairness, robustness, and explainability, enabling healthcare providers to thoroughly assess AI products before and after deployment and make informed procurement decisions.

Contact Information

Website
www.aival.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71-75 Shelton Street
  • London WC2H 9JQ
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 71-75 Shelton Street
  • London WC2H 9JQ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aival Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 07-Mar-2025 Completed Generating Revenue
3. Grant 01-Oct-2022 Completed Generating Revenue
2. Early Stage VC 31-Mar-2022 $1.05M $1.47M Completed Generating Revenue
1. Early Stage VC 15-Oct-2020 $413K $413K Completed Startup
To view Aival’s complete valuation and funding history, request access »

Aival Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Aival’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Aival Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aival Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
ScaleUps Ventures Accelerator/Incubator
Innovate UK Government
Antler Venture Capital Minority
High Growth Robotics Venture Capital Minority
To view Aival’s complete investors history, request access »

Ready to get started?

Request a free trial

Aival FAQs

  • When was Aival founded?

    Aival was founded in 2020.

  • Where is Aival headquartered?

    Aival is headquartered in London, United Kingdom.

  • What is the size of Aival?

    Aival has 5 total employees.

  • What industry is Aival in?

    Aival’s primary industry is Other Healthcare Technology Systems.

  • Is Aival a private or public company?

    Aival is a Private company.

  • What is Aival’s current revenue?

    The current revenue for Aival is .

  • How much funding has Aival raised over time?

    Aival has raised $1.47M.

  • Who are Aival’s investors?

    ScaleUps Ventures, Innovate UK, Antler, and High Growth Robotics have invested in Aival.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process